Redcare Pharmacy N.V.
SHPPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.32 | -0.36 | 1.01 | -0.09 |
| FCF Yield | -2.79% | -0.15% | 0.64% | -1.09% |
| EV / EBITDA | 89.71 | 75.79 | 297.38 | -217.73 |
| Quality | ||||
| ROIC | -0.20% | -0.16% | -1.14% | -3.07% |
| Gross Margin | 22.09% | 23.79% | 23.32% | 22.28% |
| Cash Conversion Ratio | 9.70 | -50.77 | -4.06 | 0.72 |
| Growth | ||||
| Revenue 3-Year CAGR | 20.92% | 23.98% | 25.73% | 25.32% |
| Free Cash Flow Growth | -1,112.47% | -122.37% | 156.47% | -54.71% |
| Safety | ||||
| Net Debt / EBITDA | -8.83 | -2.92 | 15.52 | -11.50 |
| Interest Coverage | -0.25 | -0.06 | -1.87 | -5.86 |
| Efficiency | ||||
| Inventory Turnover | 3.27 | 3.34 | 3.40 | 3.41 |
| Cash Conversion Cycle | 6.01 | 1.15 | 6.21 | 10.96 |